CD8A and neoplasm: Remarkably, the triple therapy was able to remodel the tight tumor stroma, which normally supports tumor growth, allowing increased trafficking of immune effector CD8 T cells and CD4 T helper cells, and reduced infiltration by myeloid suppressor cells, overall enhancing the effects of the anti-tumor immunity prompted by the oHSV.